Monday, July 16, 2001
Although Incyte Genomics Inc. believes the broad applicability of its
Genomics Knowledge Platform could provide good revenue potential in other market segments,
the company has decided it is better to maintain its focus on content, rather than
applications. Thus INCY last week licensed the platform to Secant Technologies Inc., which
provided the original software to develop GKP.
GKP is a bioinformatics suite that allows the integration